OpenVSafe by OpenVAERS
Search V-safe

9U8-22138-02778

3 vaccinations 10 coded responses 39 check-ins 10 free-text entries 10 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
997 / AK
Registered
2020-12-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Registered in v-safe
  2. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-20
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site
    Adult check-in
  4. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2020-12-22
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  9. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  11. 2020-12-24
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  12. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  13. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2020-12-26
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  17. 2021-01-10
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  18. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  19. 2021-01-14
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Redness · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  21. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  22. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea exertional — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty keeping breath when doing anything
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  24. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-01-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  26. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-01-18
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  28. 2021-01-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty breathing during mild exertion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-01-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  30. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  31. 2021-01-28
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  32. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  33. 2021-02-11
    Survey response — day 28, dose 2
    MedDRA: Dyspnoea, Fatigue, Lung disorder — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Trouble breathing, lungs feel tacky, ongoing fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  34. 2021-02-18
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  35. 2021-02-25
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  36. 2021-04-15
    Survey response — 3 months, dose 2
    MedDRA: Electrolyte imbalance — Feeling: Good
    Free text: Ever since getting the vaccine I have needed far more electrolytes to function.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  37. 2021-07-15
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  38. 2021-09-29
    Dose 3 — Pfizer-BioNTech
  39. 2021-09-29
    Health check-in — day 0, dose 3
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  40. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  41. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  42. 2021-10-02
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Hard to breathe
    MedDRA releases: 2024-11 · check-in free text available
  43. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  44. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  45. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  46. 2021-10-06
    Health check-in — day 7, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  47. 2021-10-13
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  48. 2021-10-20
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  49. 2021-10-27
    Survey response — day 28, dose 3
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Cold; or what passes for one up in Kivalina, Alaska (which I have been told is different?) came on. Not as bad as previous years thankfully.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2021-10-27
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  51. 2021-10-29
  52. 2021-11-10
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  53. 2021-12-29
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  54. 2022-04-01
    Survey response — 6 months, dose 3
    MedDRA: Dyspnoea, Headache, Nausea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Shortness of breath nausea headache
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-14Pfizer-BioNTech
32021-09-29Pfizer-BioNTech No

Call center

10 call center cases

1 unsuccessful · 9 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): Difficulty keeping breath when doing anything

2021-01-17

Systemic reaction (other): Difficulty breathing

2021-01-18

Systemic reaction (other): Difficulty breathing

2021-01-19

Systemic reaction (other): Difficulty breathing during mild exertion

2021-01-20

Systemic reaction (other): Difficulty breathing

Release 4 — day 28, dose 2

2021-02-11

Symptoms: Trouble breathing, lungs feel tacky, ongoing fatigue

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: Ever since getting the vaccine I have needed far more electrolytes to function.

Release 9 — days 1–6 daily, dose 3

2021-10-02

Systemic reaction (other): Hard to breathe

Release 10 — day 28, dose 3

2021-10-27

Symptoms: Cold; or what passes for one up in Kivalina, Alaska (which I have been told is different?) came on. Not as bad as previous years thankfully.

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Shortness of breath nausea headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDyspnoea ✓ ✓ ✓
SDElectrolyte imbalance ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDLung disorder ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDNausea · · ✓
SRODyspnoea ✓ ✓ ✓
SRODyspnoea exertional ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release